The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 19, 2019

Filed:

Oct. 08, 2014
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Universite DE Poitiers, Poitiers, FR;

University of Exeter, Exeter, Devon, GB;

Inventors:

Miroslava Spanova, Tlmace-Lipnik, SK;

Thierry Ferreira, Iteuil, FR;

Romain Clement, Poitiers, FR;

Shalinee Dhayal, Saltash Cornwall, GB;

Noël Morgan, Gunnislake Cornwall, GB;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/231 (2006.01); A61K 31/357 (2006.01); A61K 31/7032 (2006.01); A61K 31/661 (2006.01); A61K 31/232 (2006.01); A61K 31/7024 (2006.01); A61K 31/201 (2006.01); A61K 45/06 (2006.01); A23L 33/12 (2016.01); A61K 31/164 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7024 (2013.01); A23L 33/12 (2016.08); A61K 31/164 (2013.01); A61K 31/201 (2013.01); A61K 31/231 (2013.01); A61K 31/232 (2013.01); A61K 31/357 (2013.01); A61K 31/661 (2013.01); A61K 31/7032 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present invention relates to the field of medicine. It more particularly relates to the use of compounds for preventing and/or treating dyslipidemia in a subject, said dyslipidemia typically being linked to the excess presence in the biological membranes, including in the biological membranes of non-adipocyte cells, of fatty acids, in particular of saturated long-chain fatty acids, and/or of sterols. The invention also relates to compositions, in particular pharmaceutical compositions and food supplements or complements, comprising such compounds, and to the uses thereof for preventing and/or treating dyslipidemia. The compounds and compositions according to the invention can in particular be advantageously used for preventing and/or treating a pathological condition selected from metabolic syndrome and/or a symptom or abnormality characteristic of metabolic syndrome, preferably for preventing or treating type 2 diabetes mellitus or hepatic steatosis.


Find Patent Forward Citations

Loading…